Studies in CRC mouse models have found that Peptostreptococcus anaerobius can promote the recruitment of MDSCs and enhance their immunosuppressive activity, thereby eliminating the therapeutic effects of anti‐PD‐1 treatment [185]. The gene discussed is PDCD1; the disease is colorectal carcinoma.